Categories
Industry Analysis Market Reports News

The Cell Therapy Manufacturing Market is projected to grow at an annualized rate of >16.5%, till 2030

Roots Analysis has done a detailed study on Cell Therapy Manufacturing Market (3rd Edition), 2019 – 2030, covering various important aspects of the industry and identifying key future growth opportunities.

Key Market Insights

  • More than 100 industry players and over 60 non-industry players currently claim to manufacture different types of cell therapies, either for in-house requirements or on contract basis
  • The market is fragmented, featuring both established players and new entrants, which claim to operate at various scales and manufacture a diverse range of cell therapies
  • In order to cater to the growing needs of clients / sponsors, companies have established presence across different regions; presently, the US, the UK and China are the key hubs for cell therapy manufacturing
  • In recent years, a significant increase in partnership activity has been observed in this domain; in fact, therapy developers have already inked manufacturing deals with both indigenous and international experts
  • In order to enhance core competencies related to the domain, both drug developers and CMOs are actively investing in expanding their existing infrastructure and capabilities
  • Cell therapy manufacturers are also gradually opting to automate various operations in the supply chain; the primary objective is to achieve favorable bench-to-clinic timelines and cut down on production related losses
  • Currently, the installed global capacity for cell therapy manufacturing is estimated to be spread across 1.2+ million square feet of dedicated cleanroom area distributed across various scales of operation
  • More than 70,000 patients were estimated to have been enrolled in cell therapy related clinical trials; the demand for cell therapies is anticipated to grow significantly over the next decade
  • Revenues from manufacturing operations of T-cell therapies are anticipated to capture higher market share; the benefit will be realized by both autologous and allogeneic therapies across different regions the world
  • Clinical scale manufacturing operations are likely to drive the future market size, taking into consideration both in-house and contract service requirements

Read Detailed Analysis: https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html     

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Table of Contents

  1. PREFACE
    • Scope of the Report
    • Research Methodology
    • Chapter Outlines
  2. EXECUTIVE SUMMARY
  3. INTRODUCTION
    • Context and Background
    • Introduction to Cell Therapies
      • Comparison of Cell Therapies and Other Biotechnology Products
      • Classification of Advanced Therapy Medicinal Products (ATMPs)
      • Current Market Landscape of ATMPs
    • Overview of Cell Therapy Manufacturing
    • Cell Therapy Manufacturing Models
      • Centralized Manufacturing
      • Decentralized Manufacturing
    • Scalability of Cell Therapy Manufacturing
      • Scale-up
      • Scale-out
    • Types of Cell Therapy Manufacturers
    • Key Manufacturing-related Challenges
    • Factors Influencing Cell Therapy Manufacturing
    • Automating Cell Therapy Manufacturing
    • Cell Therapy Manufacturing Supply Chain
    • Future Perspectives
  4. MARKET OVERVIEW
    • Chapter Overview
    • Cell Therapy Manufacturers (Industry Players): Overall Market Landscape
      • Analysis by Location of Headquarters
      • Analysis by Location of Manufacturing Facility
      • Analysis by Type of Cells Manufactured
      • Analysis by Source of Cells
      • Analysis by Scale of Operation
      • Analysis by Type of Cell Culture
      • Analysis by Purpose of Production
      • Analysis by Manufacturing Capabilities / Services
    • Cell Therapy Manufacturers (Non-Industry Players): Overall Market Landscape
      • Analysis by Location of Headquarters
      • Analysis by Location of Manufacturing Facility
      • Analysis by Type of Cells Manufactured
      • Analysis by Source of Cells
      • Analysis by Scale of Operation
      • Analysis by Type of Cell Culture
      • Analysis by Purpose of Production
      • Analysis by Manufacturing Capabilities / Services
    • Cell Therapy Manufacturing: Role of Logistics Service Providers
  5. REGULATORY LANDSCAPE
    • Chapter Overview
    • Current Scenario
      • Regulatory Guidelines in the US
      • Regulatory Guidelines in Europe
      • Regulatory Guidelines in Japan
      • Conditional Approvals
    • Regulatory Accreditations for Cell Therapy Manufacturing
      • Facilities Approved by Regulators to Manufacture Cell Therapies
    • Summary of Guidelines for Clinical-Stage Manufacturing of Cell Therapies
    • Existing Challenges to Clinical-Stage Manufacturing
      • Variability in Regulatory Guidelines across Different Geographies
    • Conclusion
  6. ROADMAPS FOR OVERCOMING EXISTING CHALLENGES
    • Chapter Overview
    • Roadmap for the US
      • Cell Processing
      • Cell Preservation, Distribution and Handling
      • Process Automation and Data Analytics
      • Process Monitoring and Quality Control
      • Standardization and Regulatory Support
      • Workforce Development
      • Supply Chain and Logistics
    • Roadmaps for Other Geographies
      • Europe
      • Asia Pacific
  1. AUTOMATION TECHNOLOGIES FOR CELL THERAPY MANUFACTURING
    • Chapter Overview
    • Automation of Cell Therapy Manufacturing Processes
      • Closed Systems
      • Single-use Systems
      • Modular Systems
    • Case Studies
      • Roadmap to Developing an Automated Cell Manufacturing / Processing Device
      • Automating Cell Therapy Manufacturing
    • GMP-in-a-Box
    • List of Automation Service Providers
    • Comparative Analysis of Manual and Automated Processes
    • Concluding Remarks
  2. PROFILES: INDUSTRY PLAYERS
    • Chapter Overview
    • Service Providers in the US

8.2.1        Cognate BioServices

  • Company Overview
  • Service Portfolio
  • Manufacturing Capabilities
  • Partnerships
  • Future Outlook
  • FUJIFILM Cellular Dynamics
    • Company Overview
    • Service Portfolio
    • Manufacturing Capabilities
    • Partnerships
    • Future Outlook
  • KBI Biopharma
    • Company Overview
    • Service Portfolio
    • Manufacturing Capabilities
    • Partnerships
    • Future Outlook
  • Hitachi Chemical Advanced Therapeutics Solutions
    • Company Overview
    • Service Portfolio
    • Manufacturing Capabilities
    • Partnerships
    • Future Outlook
  • Waisman Biomanufacturing
    • Company Overview
    • Service Portfolio
    • Manufacturing Capabilities
    • Partnerships
    • Future Outlook
  • Service Providers in Europe
    • BioNTech Innovative Manufacturing Services
      • Company Overview
      • Service Portfolio
      • Manufacturing Capabilities
      • Partnerships
      • Future Outlook
    • Cell and Gene Therapy Catapult
      • Company Overview
      • Service Portfolio
      • Manufacturing Capabilities
      • Partnerships
      • Future Outlook
    • Lonza
      • Company Overview
      • Service Portfolio
      • Manufacturing Capabilities
      • Partnerships
      • Future Outlook
    • MaSTherCell
      • Company Overview
      • Service Portfolio
      • Manufacturing Capabilities
      • Partnerships
      • Future Outlook
    • Roslin Cell Therapies
      • Company Overview
      • Service Portfolio
      • Manufacturing Capabilities
      • Partnerships
      • Future Outlook
    • Service Providers in Asia Pacific
      • Cell Therapies
        • Company Overview
        • Service Portfolio
        • Manufacturing Capabilities
        • Partnerships
        • Future Outlook
      • Japan Tissue Engineering (J-TEC)
        • Company Overview
        • Service Portfolio
        • Manufacturing Capabilities
        • Partnerships
        • Future Outlook
      • MEDINET
        • Company Overview
        • Service Portfolio
        • Manufacturing Capabilities
        • Partnerships
        • Future Outlook
      • Nikon CeLL innovation
        • Company Overview
        • Service Portfolio
        • Manufacturing Capabilities
        • Partnerships
        • Future Outlook
      • WuXi Advanced Therapies
        • Company Overview
        • Service Portfolio
        • Manufacturing Capabilities
        • Partnerships
        • Future Outlook
  1. PROFILES: NON-INDUSTRY PLAYERS
    • Chapter Overview
    • Center for Cell and Gene Therapy, Baylor College of Medicine
      • Overview
      • Operating Segments
      • Service Portfolio
      • Manufacturing Facilities and Capabilities
    • Centre for Cell Manufacturing Ireland, National University of Ireland
      • Overview
      • Service Portfolio
      • Manufacturing Facilities and Capabilities
    • Clinical Cell and Vaccine Production Facility, University of Pennsylvania
      • Overview
      • Service Portfolio
      • Manufacturing Facilities and Capabilities
    • Guy’s and St. Thomas’ GMP Facility, Guy’s Hospital
      • Overview
      • Service Portfolio
      • Manufacturing Facilities and Capabilities
    • Laboratory for Cell and Gene Medicine, Stanford University
      • Overview
      • Service Portfolio
      • Manufacturing Facilities and Capabilities
    • Molecular and Cellular Therapeutics, University of Minnesota
      • Overview
      • Service Portfolio
      • Manufacturing Facilities and Capabilities
    • Newcastle Cellular Therapies Facility, Newcastle University
      • Overview
      • Service Portfolio
      • Manufacturing Facilities and Capabilities
    • Rayne Cell Therapy Suite, King’s College London
      • Overview
      • Manufacturing Facilities and Capabilities
    • Scottish National Blood Transfusion Services Cellular Therapy Facility, Scottish Centre for Regenerative Medicine
      • Overview
      • Manufacturing Facilities and Capabilities
    • Sydney Cell and Gene Therapy
      • Overview
      • Manufacturing Facilities and Capabilities
    • ROLE OF NON-PROFIT ORGANIZATIONS
      • Chapter Overview
      • Cell Therapy Manufacturing Service Providers: Non-Profit Organizations
        • CellCAN
        • Cell Therapy Manufacturing Cooperative Research Center (CTM CRC)
        • National Cell Manufacturing Consortium (NCMC)
        • California Institute of Regenerative Medicine (CIRM)
      • Cell Therapy Manufacturing: Affiliated International Societies
    • PARTNERSHIPS
      • Chapter Overview
      • Partnership Models
      • Cell Therapy Manufacturing: List of Partnerships
        • Analysis by Year of Partnership
        • Analysis by Type of Partnership Model
        • Analysis by Year and Type of Partnership Model
      • Analysis by Type of Cells
      • Analysis by Scale of Operation
      • Geographical Analysis
        • Continent-wise Distribution
        • Country-wise Distribution
      • Most Active Players: Analysis by Number of Partnerships
      • Cell Therapy Manufacturing: List of Acquisitions
        • Analysis by Year and Type of Cells
        • Geographical Analysis
        • Ownership Change Matrix
      • FACILITY EXPANSIONS
        • Chapter Overview
        • Cell Therapy Manufacturing: List of Expansions
          • Cumulative Year-wise Distribution
          • Analysis by Type of Cells
          • Analysis by Scale of Operation
          • Analysis by Purpose of Expansion
          • Analysis by Location of Manufacturing Facility
          • Analysis by Region and Purpose of Expansion
        • CAPACITY ANALYSIS
          • Chapter Overview
          • Key Assumptions and Methodology (Industry Players)

13.2.1      Cell Therapy Manufacturing: Installed Global Capacity (Number of Cleanrooms)

  • Analysis by Size of Manufacturer
  • Analysis by Scale of Operation
  • Analysis by Location of Manufacturing Facility
  • Cell Therapy Manufacturing: Installed Global Capacity (Cleanroom Area)
    • Analysis by Size of Manufacturer
    • Analysis by Scale of Operation
    • Analysis by Location of Manufacturing Facility

 

  • Key Assumptions and Methodology (Non-Industry Players)
    • Cell Therapy Manufacturing: Installed Global Capacity (Number of Cleanrooms)
      • Analysis by Scale of Operation
      • Analysis by Location of Manufacturing Facility
    • Cell Therapy Manufacturing: Installed Global Capacity (Cleanroom Area)
      • Analysis by Scale of Operation
      • Analysis by Location of Manufacturing Facility

13.4         Concluding Remarks

  • DEMAND ANALYSIS

14.1         Chapter Overview

14.2         Key Assumptions and Methodology

14.3         Cell Therapy Manufacturing: Overall Annual Demand

14.3.1.     Analysis by Type of Cells

14.3.2.     Analysis by Scale of Operations

14.3.3.     Analysis by Geography

  • COST PRICE ANALYSIS
    • Chapter Overview
    • Factors Contributing to the High Price of Cell Therapies
    • Pricing Models for Cell Therapies
      • Based on Associated Costs for T-cell Therapies
      • Based on Associated Costs for Stem Cell Therapies
      • Based on Availability of Competing Products
      • Based on Target Patient Segment
      • Based on Opinions of Industry Experts
    • Cell Therapy Cost Optimization
      • Role of Cost of Goods Sold
      • Role of Automation
      • Role of Cell Therapy Contract Manufacturing Organizations
    • Reimbursement-related Considerations for Cell Therapies
      • Case Study: The National Institute for Health and Care Excellence’s (NICE) Appraisal of CAR-T Therapies
    • MAKE VERSUS BUY DECISION MAKING FRAMEWORK
      • Chapter Overview
      • Make versus Buy Decision Making: Analytical Output
    • MARKET SIZING AND OPPORTUNITY ANALYSIS
      • Chapter Overview
      • Scope of the Forecast
      • Forecast Methodology
      • Input Tables and Key Assumptions
      • Overall Cell Therapy Manufacturing Market, 2019-2030
        • Cell Therapy Manufacturing Market, 2019-2030: Distribution by Type of Cell Therapy
        • Cell Therapy Manufacturing Market, 2019-2030: Distribution by Source of Cells
        • Cell Therapy Manufacturing Market, 2019-2030: Distribution by Scale of Operation
        • Cell Therapy Manufacturing Market, 2019-2030: Distribution by Purpose of
        • Production
        • Cell Therapy Manufacturing Market, 2019-2030: Geographical Distribution
      • Market Opportunity in Commercial Scale Manufacturing of Cell-based Therapies
        • Overall Commercial Scale Manufacturing Market for T-cell Therapies, 2019-2030
          • Distribution by Type of Therapy (CAR-T Therapy, TCR Therapy, and TIL Therapy)
          • Distribution by Source of Cells
          • Geographical Distribution
        • Overall Commercial Scale Manufacturing Market for Dendritic Cell and Tumor Cell Therapies, 2019-2030
          • Distribution by Type of Therapy (Dendritic Cell Therapy, and Tumor Cell Therapy)
          • Distribution by Source of Cells
          • Geographical Distribution
        • Overall Commercial Scale Manufacturing Market for NK Cell Therapies, 2019-2030
          • Distribution by Source of Cells
          • Geographical Distribution
        • Overall Commercial Scale Manufacturing Market for Stem Cell Therapies, 2019-2030
          • Distribution by Source of Cells
          • Geographical Distribution
        • Market Opportunity in Clinical Scale Manufacturing of Cell-based Therapies
          • Overall Clinical Scale Manufacturing Market for T-cell Therapies, 2019-2030
            • Distribution by Type of Therapy (CAR-T Therapy, TCR Therapy and TIL Therapy)
            • Distribution by Source of Cells
            • Geographical Distribution
          • Overall Clinical Scale Manufacturing Market for Dendritic Cell and Tumor Cell Therapies, 2019-2030
            • Distribution by Type of Therapy (Dendritic Cell Therapy, Tumor Cell Therapy)
            • Distribution by Source of Cells
            • Geographical Distribution
          • Overall Clinical Scale Manufacturing Market for NK Cell Therapies, 2019-2030
            • Distribution by Source of Cells
            • Geographical Distribution
          • Overall Clinical Scale Manufacturing Market for Stem Cell Therapies, 2019-2030
            • Distribution by Source of Cells
            • Geographical Distribution
          • KEY INSIGHTS
            • Chapter Overview
            • Cell Therapy Manufacturers: Grid Analysis
            • Cell Therapy Manufacturers: Logo Landscape by Type of Cell Therapy
              • Logo Landscape: Immune Cell Manufacturers
              • Logo Landscape: Stem Cell Manufacturers
            • Cell Therapy Manufacturers: World Map Representation of Location of Manufacturing Facility
              • Industry Players
              • Non-Industry Players
            • SWOT ANALYSIS
              • Chapter Overview
              • Strengths
              • Weaknesses
              • Opportunities
              • Threats
              • Comparison of SWOT Factors
                • Concluding Remarks
              • CONCLUSION
                • Chapter Overview
                • Key Takeaways
              • SURVEY ANALYSIS
                • Chapter Overview
                • Seniority Level of Respondents
                • Type of Cell Therapy
                • Scale of Operation
                • Source of Cells
                • Type of Cell Culture System

22.7.        Availability of Fill / Finish Services

  • INTERVIEW TRANSCRIPTS
    • Chapter Overview
    • Lion TCR
      • Company Overview
      • Interview Transcript: Victor Lietao Li, Co-Founder and Chief Executive Officer
    • Cell Therapies
      • Company Overview
      • Interview Transcript: Tim Oldham, Chief Executive Officer
    • CiMaas
      • Company Overview
      • Interview Transcript: Gerard MJ Bos, Chief Executive Officer
    • Gracell Biotechnologies
      • Company Overview
      • Interview Transcript: Wei (William) Cao, Chief Executive Officer
    • Glycostem Therapeutics
      • Company Overview
      • Interview Transcript: Troels Jordansen, Chief Executive Officer
    • Kadimastem
      • Company Overview
      • Interview Transcript: Arik Hasson, Executive VP Research and Development
    • Bio Elpida
      • Company Overview
      • Interview Transcript: Gilles Devillers, General Manager
    • Center for Commercialization of Cancer Immunotherapy / C3i
      • Company Overview
      • Interview Transcript: Arnaud Deladeriere, Manager, Business Development & Operations-cGMP Manufacturing Unit
    • Waisman Biomanufacturing
      • Company Overview
      • Interview Transcript: Brian Dattilo, Manager of Business Development
    • RoslinCT
      • Company Overview
      • Interview Transcript: Fiona Bellot, Business Development Manager
    • Yposkesi
      • Company Overview
      • Interview Transcript: Mathilde Girard, Leader, Cell Therapy Innovation and Development
    • University of Minnesota
      • Organization Overview
      • Interview Transcript: David Mckenna, Professor and American Red in Transfusion Medicine
    • APPENDIX 1: TABULATED DATA
    • APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html    

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]

Categories
Industry Analysis Market Reports News

The Cell Therapy Manufacturing Market is projected to grow at an annualized rate of >16.5%, till 2030

Roots Analysis has done a detailed study on Cell Therapy Manufacturing Market (3rd Edition), 2019 – 2030, covering various important aspects of the industry and identifying key future growth opportunities.

Key Market Insights

  • More than 100 industry players and over 60 non-industry players currently claim to manufacture different types of cell therapies, either for in-house requirements or on contract basis
  • The market is fragmented, featuring both established players and new entrants, which claim to operate at various scales and manufacture a diverse range of cell therapies
  • In order to cater to the growing needs of clients / sponsors, companies have established presence across different regions; presently, the US, the UK and China are the key hubs for cell therapy manufacturing
  • In recent years, a significant increase in partnership activity has been observed in this domain; in fact, therapy developers have already inked manufacturing deals with both indigenous and international experts
  • In order to enhance core competencies related to the domain, both drug developers and CMOs are actively investing in expanding their existing infrastructure and capabilities
  • Cell therapy manufacturers are also gradually opting to automate various operations in the supply chain; the primary objective is to achieve favorable bench-to-clinic timelines and cut down on production related losses
  • Currently, the installed global capacity for cell therapy manufacturing is estimated to be spread across 1.2+ million square feet of dedicated cleanroom area distributed across various scales of operation
  • More than 70,000 patients were estimated to have been enrolled in cell therapy related clinical trials; the demand for cell therapies is anticipated to grow significantly over the next decade
  • Revenues from manufacturing operations of T-cell therapies are anticipated to capture higher market share; the benefit will be realized by both autologous and allogeneic therapies across different regions the world
  • Clinical scale manufacturing operations are likely to drive the future market size, taking into consideration both in-house and contract service requirements

Read Detailed Analysis: https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html     

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Table of Contents

  1. PREFACE
    • Scope of the Report
    • Research Methodology
    • Chapter Outlines
  2. EXECUTIVE SUMMARY
  3. INTRODUCTION
    • Context and Background
    • Introduction to Cell Therapies
      • Comparison of Cell Therapies and Other Biotechnology Products
      • Classification of Advanced Therapy Medicinal Products (ATMPs)
      • Current Market Landscape of ATMPs
    • Overview of Cell Therapy Manufacturing
    • Cell Therapy Manufacturing Models
      • Centralized Manufacturing
      • Decentralized Manufacturing
    • Scalability of Cell Therapy Manufacturing
      • Scale-up
      • Scale-out
    • Types of Cell Therapy Manufacturers
    • Key Manufacturing-related Challenges
    • Factors Influencing Cell Therapy Manufacturing
    • Automating Cell Therapy Manufacturing
    • Cell Therapy Manufacturing Supply Chain
    • Future Perspectives
  4. MARKET OVERVIEW
    • Chapter Overview
    • Cell Therapy Manufacturers (Industry Players): Overall Market Landscape
      • Analysis by Location of Headquarters
      • Analysis by Location of Manufacturing Facility
      • Analysis by Type of Cells Manufactured
      • Analysis by Source of Cells
      • Analysis by Scale of Operation
      • Analysis by Type of Cell Culture
      • Analysis by Purpose of Production
      • Analysis by Manufacturing Capabilities / Services
    • Cell Therapy Manufacturers (Non-Industry Players): Overall Market Landscape
      • Analysis by Location of Headquarters
      • Analysis by Location of Manufacturing Facility
      • Analysis by Type of Cells Manufactured
      • Analysis by Source of Cells
      • Analysis by Scale of Operation
      • Analysis by Type of Cell Culture
      • Analysis by Purpose of Production
      • Analysis by Manufacturing Capabilities / Services
    • Cell Therapy Manufacturing: Role of Logistics Service Providers
  5. REGULATORY LANDSCAPE
    • Chapter Overview
    • Current Scenario
      • Regulatory Guidelines in the US
      • Regulatory Guidelines in Europe
      • Regulatory Guidelines in Japan
      • Conditional Approvals
    • Regulatory Accreditations for Cell Therapy Manufacturing
      • Facilities Approved by Regulators to Manufacture Cell Therapies
    • Summary of Guidelines for Clinical-Stage Manufacturing of Cell Therapies
    • Existing Challenges to Clinical-Stage Manufacturing
      • Variability in Regulatory Guidelines across Different Geographies
    • Conclusion
  6. ROADMAPS FOR OVERCOMING EXISTING CHALLENGES
    • Chapter Overview
    • Roadmap for the US
      • Cell Processing
      • Cell Preservation, Distribution and Handling
      • Process Automation and Data Analytics
      • Process Monitoring and Quality Control
      • Standardization and Regulatory Support
      • Workforce Development
      • Supply Chain and Logistics
    • Roadmaps for Other Geographies
      • Europe
      • Asia Pacific
  1. AUTOMATION TECHNOLOGIES FOR CELL THERAPY MANUFACTURING
    • Chapter Overview
    • Automation of Cell Therapy Manufacturing Processes
      • Closed Systems
      • Single-use Systems
      • Modular Systems
    • Case Studies
      • Roadmap to Developing an Automated Cell Manufacturing / Processing Device
      • Automating Cell Therapy Manufacturing
    • GMP-in-a-Box
    • List of Automation Service Providers
    • Comparative Analysis of Manual and Automated Processes
    • Concluding Remarks
  2. PROFILES: INDUSTRY PLAYERS
    • Chapter Overview
    • Service Providers in the US

8.2.1        Cognate BioServices

  • Company Overview
  • Service Portfolio
  • Manufacturing Capabilities
  • Partnerships
  • Future Outlook
  • FUJIFILM Cellular Dynamics
    • Company Overview
    • Service Portfolio
    • Manufacturing Capabilities
    • Partnerships
    • Future Outlook
  • KBI Biopharma
    • Company Overview
    • Service Portfolio
    • Manufacturing Capabilities
    • Partnerships
    • Future Outlook
  • Hitachi Chemical Advanced Therapeutics Solutions
    • Company Overview
    • Service Portfolio
    • Manufacturing Capabilities
    • Partnerships
    • Future Outlook
  • Waisman Biomanufacturing
    • Company Overview
    • Service Portfolio
    • Manufacturing Capabilities
    • Partnerships
    • Future Outlook
  • Service Providers in Europe
    • BioNTech Innovative Manufacturing Services
      • Company Overview
      • Service Portfolio
      • Manufacturing Capabilities
      • Partnerships
      • Future Outlook
    • Cell and Gene Therapy Catapult
      • Company Overview
      • Service Portfolio
      • Manufacturing Capabilities
      • Partnerships
      • Future Outlook
    • Lonza
      • Company Overview
      • Service Portfolio
      • Manufacturing Capabilities
      • Partnerships
      • Future Outlook
    • MaSTherCell
      • Company Overview
      • Service Portfolio
      • Manufacturing Capabilities
      • Partnerships
      • Future Outlook
    • Roslin Cell Therapies
      • Company Overview
      • Service Portfolio
      • Manufacturing Capabilities
      • Partnerships
      • Future Outlook
    • Service Providers in Asia Pacific
      • Cell Therapies
        • Company Overview
        • Service Portfolio
        • Manufacturing Capabilities
        • Partnerships
        • Future Outlook
      • Japan Tissue Engineering (J-TEC)
        • Company Overview
        • Service Portfolio
        • Manufacturing Capabilities
        • Partnerships
        • Future Outlook
      • MEDINET
        • Company Overview
        • Service Portfolio
        • Manufacturing Capabilities
        • Partnerships
        • Future Outlook
      • Nikon CeLL innovation
        • Company Overview
        • Service Portfolio
        • Manufacturing Capabilities
        • Partnerships
        • Future Outlook
      • WuXi Advanced Therapies
        • Company Overview
        • Service Portfolio
        • Manufacturing Capabilities
        • Partnerships
        • Future Outlook
  1. PROFILES: NON-INDUSTRY PLAYERS
    • Chapter Overview
    • Center for Cell and Gene Therapy, Baylor College of Medicine
      • Overview
      • Operating Segments
      • Service Portfolio
      • Manufacturing Facilities and Capabilities
    • Centre for Cell Manufacturing Ireland, National University of Ireland
      • Overview
      • Service Portfolio
      • Manufacturing Facilities and Capabilities
    • Clinical Cell and Vaccine Production Facility, University of Pennsylvania
      • Overview
      • Service Portfolio
      • Manufacturing Facilities and Capabilities
    • Guy’s and St. Thomas’ GMP Facility, Guy’s Hospital
      • Overview
      • Service Portfolio
      • Manufacturing Facilities and Capabilities
    • Laboratory for Cell and Gene Medicine, Stanford University
      • Overview
      • Service Portfolio
      • Manufacturing Facilities and Capabilities
    • Molecular and Cellular Therapeutics, University of Minnesota
      • Overview
      • Service Portfolio
      • Manufacturing Facilities and Capabilities
    • Newcastle Cellular Therapies Facility, Newcastle University
      • Overview
      • Service Portfolio
      • Manufacturing Facilities and Capabilities
    • Rayne Cell Therapy Suite, King’s College London
      • Overview
      • Manufacturing Facilities and Capabilities
    • Scottish National Blood Transfusion Services Cellular Therapy Facility, Scottish Centre for Regenerative Medicine
      • Overview
      • Manufacturing Facilities and Capabilities
    • Sydney Cell and Gene Therapy
      • Overview
      • Manufacturing Facilities and Capabilities
    • ROLE OF NON-PROFIT ORGANIZATIONS
      • Chapter Overview
      • Cell Therapy Manufacturing Service Providers: Non-Profit Organizations
        • CellCAN
        • Cell Therapy Manufacturing Cooperative Research Center (CTM CRC)
        • National Cell Manufacturing Consortium (NCMC)
        • California Institute of Regenerative Medicine (CIRM)
      • Cell Therapy Manufacturing: Affiliated International Societies
    • PARTNERSHIPS
      • Chapter Overview
      • Partnership Models
      • Cell Therapy Manufacturing: List of Partnerships
        • Analysis by Year of Partnership
        • Analysis by Type of Partnership Model
        • Analysis by Year and Type of Partnership Model
      • Analysis by Type of Cells
      • Analysis by Scale of Operation
      • Geographical Analysis
        • Continent-wise Distribution
        • Country-wise Distribution
      • Most Active Players: Analysis by Number of Partnerships
      • Cell Therapy Manufacturing: List of Acquisitions
        • Analysis by Year and Type of Cells
        • Geographical Analysis
        • Ownership Change Matrix
      • FACILITY EXPANSIONS
        • Chapter Overview
        • Cell Therapy Manufacturing: List of Expansions
          • Cumulative Year-wise Distribution
          • Analysis by Type of Cells
          • Analysis by Scale of Operation
          • Analysis by Purpose of Expansion
          • Analysis by Location of Manufacturing Facility
          • Analysis by Region and Purpose of Expansion
        • CAPACITY ANALYSIS
          • Chapter Overview
          • Key Assumptions and Methodology (Industry Players)

13.2.1      Cell Therapy Manufacturing: Installed Global Capacity (Number of Cleanrooms)

  • Analysis by Size of Manufacturer
  • Analysis by Scale of Operation
  • Analysis by Location of Manufacturing Facility
  • Cell Therapy Manufacturing: Installed Global Capacity (Cleanroom Area)
    • Analysis by Size of Manufacturer
    • Analysis by Scale of Operation
    • Analysis by Location of Manufacturing Facility

 

  • Key Assumptions and Methodology (Non-Industry Players)
    • Cell Therapy Manufacturing: Installed Global Capacity (Number of Cleanrooms)
      • Analysis by Scale of Operation
      • Analysis by Location of Manufacturing Facility
    • Cell Therapy Manufacturing: Installed Global Capacity (Cleanroom Area)
      • Analysis by Scale of Operation
      • Analysis by Location of Manufacturing Facility

13.4         Concluding Remarks

  • DEMAND ANALYSIS

14.1         Chapter Overview

14.2         Key Assumptions and Methodology

14.3         Cell Therapy Manufacturing: Overall Annual Demand

14.3.1.     Analysis by Type of Cells

14.3.2.     Analysis by Scale of Operations

14.3.3.     Analysis by Geography

  • COST PRICE ANALYSIS
    • Chapter Overview
    • Factors Contributing to the High Price of Cell Therapies
    • Pricing Models for Cell Therapies
      • Based on Associated Costs for T-cell Therapies
      • Based on Associated Costs for Stem Cell Therapies
      • Based on Availability of Competing Products
      • Based on Target Patient Segment
      • Based on Opinions of Industry Experts
    • Cell Therapy Cost Optimization
      • Role of Cost of Goods Sold
      • Role of Automation
      • Role of Cell Therapy Contract Manufacturing Organizations
    • Reimbursement-related Considerations for Cell Therapies
      • Case Study: The National Institute for Health and Care Excellence’s (NICE) Appraisal of CAR-T Therapies
    • MAKE VERSUS BUY DECISION MAKING FRAMEWORK
      • Chapter Overview
      • Make versus Buy Decision Making: Analytical Output
    • MARKET SIZING AND OPPORTUNITY ANALYSIS
      • Chapter Overview
      • Scope of the Forecast
      • Forecast Methodology
      • Input Tables and Key Assumptions
      • Overall Cell Therapy Manufacturing Market, 2019-2030
        • Cell Therapy Manufacturing Market, 2019-2030: Distribution by Type of Cell Therapy
        • Cell Therapy Manufacturing Market, 2019-2030: Distribution by Source of Cells
        • Cell Therapy Manufacturing Market, 2019-2030: Distribution by Scale of Operation
        • Cell Therapy Manufacturing Market, 2019-2030: Distribution by Purpose of
        • Production
        • Cell Therapy Manufacturing Market, 2019-2030: Geographical Distribution
      • Market Opportunity in Commercial Scale Manufacturing of Cell-based Therapies
        • Overall Commercial Scale Manufacturing Market for T-cell Therapies, 2019-2030
          • Distribution by Type of Therapy (CAR-T Therapy, TCR Therapy, and TIL Therapy)
          • Distribution by Source of Cells
          • Geographical Distribution
        • Overall Commercial Scale Manufacturing Market for Dendritic Cell and Tumor Cell Therapies, 2019-2030
          • Distribution by Type of Therapy (Dendritic Cell Therapy, and Tumor Cell Therapy)
          • Distribution by Source of Cells
          • Geographical Distribution
        • Overall Commercial Scale Manufacturing Market for NK Cell Therapies, 2019-2030
          • Distribution by Source of Cells
          • Geographical Distribution
        • Overall Commercial Scale Manufacturing Market for Stem Cell Therapies, 2019-2030
          • Distribution by Source of Cells
          • Geographical Distribution
        • Market Opportunity in Clinical Scale Manufacturing of Cell-based Therapies
          • Overall Clinical Scale Manufacturing Market for T-cell Therapies, 2019-2030
            • Distribution by Type of Therapy (CAR-T Therapy, TCR Therapy and TIL Therapy)
            • Distribution by Source of Cells
            • Geographical Distribution
          • Overall Clinical Scale Manufacturing Market for Dendritic Cell and Tumor Cell Therapies, 2019-2030
            • Distribution by Type of Therapy (Dendritic Cell Therapy, Tumor Cell Therapy)
            • Distribution by Source of Cells
            • Geographical Distribution
          • Overall Clinical Scale Manufacturing Market for NK Cell Therapies, 2019-2030
            • Distribution by Source of Cells
            • Geographical Distribution
          • Overall Clinical Scale Manufacturing Market for Stem Cell Therapies, 2019-2030
            • Distribution by Source of Cells
            • Geographical Distribution
          • KEY INSIGHTS
            • Chapter Overview
            • Cell Therapy Manufacturers: Grid Analysis
            • Cell Therapy Manufacturers: Logo Landscape by Type of Cell Therapy
              • Logo Landscape: Immune Cell Manufacturers
              • Logo Landscape: Stem Cell Manufacturers
            • Cell Therapy Manufacturers: World Map Representation of Location of Manufacturing Facility
              • Industry Players
              • Non-Industry Players
            • SWOT ANALYSIS
              • Chapter Overview
              • Strengths
              • Weaknesses
              • Opportunities
              • Threats
              • Comparison of SWOT Factors
                • Concluding Remarks
              • CONCLUSION
                • Chapter Overview
                • Key Takeaways
              • SURVEY ANALYSIS
                • Chapter Overview
                • Seniority Level of Respondents
                • Type of Cell Therapy
                • Scale of Operation
                • Source of Cells
                • Type of Cell Culture System

22.7.        Availability of Fill / Finish Services

  • INTERVIEW TRANSCRIPTS
    • Chapter Overview
    • Lion TCR
      • Company Overview
      • Interview Transcript: Victor Lietao Li, Co-Founder and Chief Executive Officer
    • Cell Therapies
      • Company Overview
      • Interview Transcript: Tim Oldham, Chief Executive Officer
    • CiMaas
      • Company Overview
      • Interview Transcript: Gerard MJ Bos, Chief Executive Officer
    • Gracell Biotechnologies
      • Company Overview
      • Interview Transcript: Wei (William) Cao, Chief Executive Officer
    • Glycostem Therapeutics
      • Company Overview
      • Interview Transcript: Troels Jordansen, Chief Executive Officer
    • Kadimastem
      • Company Overview
      • Interview Transcript: Arik Hasson, Executive VP Research and Development
    • Bio Elpida
      • Company Overview
      • Interview Transcript: Gilles Devillers, General Manager
    • Center for Commercialization of Cancer Immunotherapy / C3i
      • Company Overview
      • Interview Transcript: Arnaud Deladeriere, Manager, Business Development & Operations-cGMP Manufacturing Unit
    • Waisman Biomanufacturing
      • Company Overview
      • Interview Transcript: Brian Dattilo, Manager of Business Development
    • RoslinCT
      • Company Overview
      • Interview Transcript: Fiona Bellot, Business Development Manager
    • Yposkesi
      • Company Overview
      • Interview Transcript: Mathilde Girard, Leader, Cell Therapy Innovation and Development
    • University of Minnesota
      • Organization Overview
      • Interview Transcript: David Mckenna, Professor and American Red in Transfusion Medicine
    • APPENDIX 1: TABULATED DATA
    • APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html    

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]

Categories
News

Cell Therapy Manufacturing Market is estimated to reach close to USD 11 Billion by 2030

Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise, they are also becoming increasingly reliant on contract service providers

Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Therapy Manufacturing Market (3rd Edition), 2019 – 2030.”

The report features an extensive study of the current market landscape and future opportunities associated with cell therapy manufacturing. It focuses on both contract manufacturers, as well as developers with in-house manufacturing facilities, offering in-depth analyses of the various business entities that are engaged in this domain, across different global regions. Amongst other elements, the report includes:

  • An analysis of the various expansion initiatives undertaken by service providers, in order to augment their respective cell therapy manufacturing capabilities, over the period 2015-2019.
  • An analysis of the recent partnerships focused on the manufacturing of cell-based therapies, which have been established in the period 2014-2019.
  • Informed estimates of the annual commercial and clinical demand for cell therapies, in terms of number of cells produced and area dedicated to manufacturing.
  • An estimate of the overall, installed capacity for manufacturing cell-based therapies based on information reported by industry stakeholders in the public domain A competitiveness analysis of biological targets, featuring insightful pictorial summaries and representations.
  • A detailed analysis of the various factors that are likely to influence the pricing of cell-based therapies, featuring different models / approaches that may be adopted by manufacturers while deciding the prices of their proprietary offerings.
  • A qualitative analysis, highlighting the various factors that need to be taken into consideration by cell therapy developers while deciding whether to manufacture their respective products in-house or engage the services of a CMO.
  • An elaborate discussion on the role of automation technologies in improving current manufacturing methods.
  • A discussion on cell therapy manufacturing regulations across various geographies, including North America, Europe, and Asia Pacific.
  • Elaborate profiles of key players (industry and non-industry) that offer contract manufacturing services.
  • A discussion on affiliated trends, key drivers and challenges, which are likely to impact the industry’s evolution, under a comprehensive SWOT framework.

Read Detailed Analysis: https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html     

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Type of therapy

  • T-cell therapies (CAR-T therapies, TCR therapies, TIL therapies)
  • Dendritic cell therapies
  • Tumor cell therapies
  • NK cell therapies
  • Stem cell therapies

Source of cells

  • Autologous
  • Allogeneic

Scale of operation

  • Clinical
  • Commercial

Purpose of manufacturing

  • Contract manufacturing
  • In-house manufacturing

Key geographical regions

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Key companies covered in the report

  • BioNTech Innovative Manufacturing Services
  • Cell Therapies
  • Cell and Gene Therapy Catapult
  • Center for Cell and Gene Therapy, Baylor College of Medicine
  • Centre for Cell Manufacturing Ireland, National University of Ireland
  • Clinical Cell and Vaccine Production Facility, University of Pennsylvania
  • Cognate BioServices
  • FUJIFILM
  • Guy’s and St. Thomas’ GMP Facility, Guy’s Hospital
  • Hitachi Chemical
  • KBI Biopharma
  • Laboratory for Cell and Gene Medicine, Stanford University
  • Lonza
  • MaSTherCell
  • MEDINET
  • Molecular and Cellular Therapeutics, University of Minnesota
  • Newcastle Cellular Therapies Facility, Newcastle University
  • Nikon CeLL innovation
  • Rayne Cell Therapy Suite, King’s College London
  • Roslin Cell Therapies
  • Scottish National Blood Transfusion Services Cellular Therapy Facility, Scottish Centre for Regenerative Medicine
  • Sydney Cell and Gene Therapy
  • WuXi Advanced Therapies

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html    

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]

Categories
News

Detailed analysis of the competitive landscape in the Global Cell Therapy Manufacturing Market by 2030

The approval of KYMRIAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity

Roots Analysis has announced the addition of Cell Therapy Manufacturing Market (3rd Edition), 2019 – 2030 report to its list of offerings.

Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity. In this context, automation is expected to be a key enabler within the cell therapy manufacturing and contract services industry.

To order this 500+ page report, which features 160+ figures and 250+ tables, please visit this link

Key Market Insights 

More than 160 organizations claim to be engaged in cell therapy manufacturing
The market landscape is dominated by industry players, representing more than 60% of the total number of stakeholders. Amongst these, over 55 are large or mid-sized firms (having more than 50 employees).

100+ players focused on T-cell and stem cell therapies
Most of these players are focused on manufacturing T-cell therapies, including CART, TCR or TILs. It is worth highlighting that more than 35 organizations claim to have necessary capabilities for the manufacturing of both types of therapies.

Presently, 70+ companies have commercial scale capacity 
As majority of the cell therapy products are in clinical trials, the demand is high at this scale. However, it is worth noting that several players (~50%) have already developed commercial scale capacity for cell therapies.

Europe is currently considered a current hub for cell therapy production
More than 220 manufacturing facilities have been established by various players, worldwide; of these, 35% are in Europe, followed by those based in North America. Other emerging regions include Australia, China, Japan, Singapore, South Korea and Israel.

50+ facility expansions reported between 2015-2019
More than 85% of the expansions are related to setting up of new facilities across different regions. Maximum expansion activity was observed in the US and in certain countries within the Asia Pacific regions.

20+ companies offer automated solutions to cell therapy developers 
Players that claim to offer consultancy services related to automation include (in alphabetical order) Berkeley Lights, Cesca Therapeutics, Ferrologix, FluDesign Sonics, GE Healthcare and Terumo BCT. Further, we identified players, namely (in alphabetical order) Fraunhofer Institute for Manufacturing Engineering and Automation IPA, Invetech, KMC Systems, Mayo Clinic Center for Regenerative Medicine and RoosterBio, that offer consultancy solutions related to automation.

Partnership activity has grown at an annualized rate of 16%, between 2014 and 2018
More than 200 agreements have been inked in the last 5 years; majority of these were focused on the supply of cell-based therapy products for clinical trials. Other popular types of collaboration models include manufacturing process development agreements (16%), services agreements (12%) and acquisitions (10%).

By 2030, developed geographies will capture over 60% of the market share
Asia Pacific is anticipated to capture the major share (~36%) of the market by 2030. It is also important to highlight that financial resources, technical expertise and established infrastructure is likely to drive cell therapy manufacturing market in Europe, which is estimated to grow at a CAGR of ~26%.

To request a sample copy / brochure of this report, please visit this link    

Key Questions Answered
  • What is the global demand for cell-based therapies?
  • Who are the key manufacturers (industry / non-industry) of cell-based therapies, across the world?
  • What are the major recent developments (such as partnerships and expansions) in this industry?
  • What kind of partnership models are commonly adopted by stakeholders in this domain?
  • What is the current, installed contract manufacturing capacity for cell therapies?
  • What are the key factors influencing the make (manufacture in-house) versus buy (outsource) decision related to cell therapies?
  • What are the key parameters governing the cost of cell therapy manufacturing?
  • What are important technology platforms (available / under development) for cell therapy development and manufacturing?
  • What are the key drivers and growth constraints in cell therapy manufacturing market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

The USD 10+ billion (by 2030) financial opportunity within the cell therapy manufacturing market has been analyzed across the following segments:

  • Type of therapy
    • T-cell therapies (CAR-T therapies, TCR therapies, TIL therapies)
    • Dendritic cell therapies
    • Tumor cell therapies
    • Stem cell therapies
  • Source of cells
    • Autologous
    • Allogeneic
  • Scale of operation
    • Clinical
    • Commercial
  • Purpose of manufacturing
    • Contract manufacturing
    • In-house manufacturing
  • Key geographical regions 
    • North America
    • Europe
    • Asia Pacific
    • Rest of the world

The report features inputs from eminent industry stakeholders, according to whom the manufacturing of cell therapies is largely being outsourced due to exorbitant costs associated with the setting-up of in-house expertise. The report includes detailed transcripts of discussions held with the following experts:

  • Victor Lietao Li (Co-Founder and Chief Executive Officer, Lion TCR)
  • Tim Oldham (Chief Executive Officer, Cell Therapies)
  • Gerard MJ Bos (Chief Executive Officer, CiMaas)
  • Wei (William) Cao (Chief Executive Officer, Gracell Biotechnologies)
  • Troels Jordansen (Chief Executive Officer, Glycostem Therapeutics)
  • Arik Hasson (Executive VP Research and Development, Kadimastem)
  • Gilles Devillers (General Manager, Bio Elpida)
  • Arnaud Deladeriere (Manager, Business Development & Operations-cGMP Manufacturing Unit, Center of Excellence for Cellular Therapy / C3i)
  • Brian Dattilo (Manager of Business Development, Waisman Biomanufacturing)
  • Fiona Bellot (Business Development Manager, RoslinCT)
  • Mathilde Girard (Department Leader, Cell Therapy Innovation and Development, YposKesi)
  • David Mckenna (Professor and American Red Cross Chair in Transfusion Medicine, University of Minnesota)

The research covers profiles of key players (industry and non-industry) that offer manufacturing services for cell-based therapies, featuring a company overview, information on manufacturing facilities, and recent collaborations. 

  • BioNTech Innovative Manufacturing Services
  • Cell Therapies
  • Cell and Gene Therapy Catapult
  • Center for Cell and Gene Therapy, Baylor College of Medicine
  • Centre for Cell Manufacturing Ireland, National University of Ireland
  • Clinical Cell and Vaccine Production Facility, University of Pennsylvania
  • Cognate BioServices
  • FUJIFILM
  • Guy’s and St. Thomas’ GMP Facility, Guy’s Hospital
  • Hitachi Chemical
  • KBI Biopharma
  • Laboratory for Cell and Gene Medicine, Stanford University
  • Lonza
  • MaSTherCell
  • MEDINET
  • Molecular and Cellular Therapeutics, University of Minnesota
  • Newcastle Cellular Therapies Facility, Newcastle University
  • Nikon CeLL innovation
  • Rayne Cell Therapy Suite, King’s College London
  • Roslin Cell Therapies
  • Scottish National Blood Transfusion Services Cellular Therapy Facility, Scottish Centre for Regenerative Medicine
  • Sydney Cell and Gene Therapy
  • WuXi Advanced Therapies

For additional details, please visit 
https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html or email [email protected] 

You may also be interested in the following titles: 

  1. Cell and Advanced Therapies Supply Chain Management Market, 2019-2030
  2. RNAi Therapeutics Market (2nd Edition), 2019 – 2030
  3. Gene Therapy Market (3rd Edition), 2019 – 2030
  4. Stem Cell Therapy Contract Manufacturing Market, 2019-2030

Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
[email protected]

Categories
News

Cell Therapy Manufacturing Market to be Worth USD 8 billion by 2030, predicts Roots Analysis

Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (2nd Edition), 2018-2030” report to its list of offerings.

Natasha Thakur, the principal analyst, stated, “The growing number of cell therapy candidates continues to create an increasing demand for facilities that offer manufacturing services for these complex pharmacological interventions. Presently, over 145 companies / organizations are actively offering manufacturing services for such products. The installed global manufacturing capacity is estimated to be over 1 billion sq ft, with the maximum capacity available in North America”

The report presents opinions on several key aspects of the market. Among other elements, it includes:

  • A detailed assessment of the current market landscape of cell therapy manufacturers, providing information on their headquarters, manufacturing facilities, type of cells handled (immune cells (such as T cells, dendritic cells, NK cells), stem cells (such as adult stem cells, human embryonic stem cells and induced pluripotent stem cells) and others), purpose of production (fulfilling in-house requirements / as a contract service provider), scale of operation (preclinical, clinical and commercial), source of cells (autologous and allogeneic) and type of cell cultures (adherent and suspension). The market features a mix of industry players and non-industry players.More than 60 non-industry players, including universities, research institutes and hospitals, are currently involved in manufacturing of cell-based therapies.
  • An estimate of the installed cell therapy manufacturing capacity, in terms of number of cleanrooms and dedicated area, distributed by type of manufacturers (industry / non-industry), size of manufacturers (small-sized, mid-sized and large-sized organizations), geographical location (North America, EU and Asia-Pacific) and scale of operation (clinical and commercial). Over 40% of 200+ manufacturing facilities are located in Europe; this is followed by North America, wherein approximately 38% of the world’s cell therapy manufacturing facilities are based. Other emerging pockets for cell therapy manufacturing include Australia, China, Japan, Singapore, South Korea and Israel; it is worth highlighting that facilities in these regions primarily cater to markets in the Asia-Pacific region only.
  • Detailed profiles of key players (industry and non-industry) that offer contract manufacturing services for cell-based therapies; each profile presents an overview of the company, information on its manufacturing facilities, and recent collaborations.
  • An elaborate discussion on the role of automation technologies in optimizing current manufacturing practices. Nearly 15 companies are actively providing support to cell therapy developers to improve their manufacturing process; these include (in alphabetical order) Berkeley Lights, Cesca Therapeutics, Ferrologix, FluDesign Sonics, GE Healthcare and Terumo BCT. Furthermore, five players, namely (in alphabetical order) Fraunhofer Institute for Manufacturing Engineering and Automation IPA, Invetech, KMC Systems, Mayo Clinic Center for Regenerative Medicine and RoosterBio, offer consultancy solutions related to automation.
  • An analysis of the various factors that are likely to influence the pricing of cell-based therapies, featuring different models/approaches that may be adopted by manufacturers to decide the prices of these therapies.
  • An analysis of over 150 collaborations focused on the manufacturing of cell-based therapies; the analysis is based on various parameters, such as the year in which the agreement was signed, type of agreement, and scale of operation (clinical and / or commercial). It is worth mentioning that, in the last three years, there has been a marked increase in number of collaborations focused on upgrading existing manufacturing processes. Examples of the companies that have entered into such deals include (in alphabetical order) ATMI, GE Healthcare, Hielscher Ultrasonics, Invetech, Pall, Reinnervate, Terumo BCT and Tokyo Electron.
  • A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in development and / or manufacturing of cell-based therapies.
  • A robust market forecast analysis, highlighting the current value and future potential of the cell therapy manufacturing market, based on various parameters, such as type of cell therapy, source of cells, scale of operation, regional distribution and purpose of manufacturing. Driven by the rapidly evolving pipeline of advanced therapies and the increasing adoption of automated technologies, the cell therapy manufacturing market is expected to grow at an accelerated pace and be worth over USD 8 billion by 2030. T-cell therapies currently capture the largest share (~65%) in the market; this trend is unlikely to change during the forecast period.

The report features inputs from a number of eminent industry stakeholders. Thakur remarked, “Most of the experts we spoke to confirmed that the manufacturing of cell therapies is largely being outsourced due to exorbitant costs associated with setting-up such facilities.” The report features detailed transcripts of discussions held with the following experts:

  • Arnaud Deladeriere (Manager, Business Development & Operations-cGMP Manufacturing Unit, C3i Center for Commercialization of Cancer Immunotherapy)
  • Tim Oldham (Chief Executive Officer, Cell Therapies)
  • Gerard MJ Bos (Chief Executive Officer, CiMaas)
  • Victor Lietao Li (Co-Founder and Chief Executive Officer, Lion TCR)
  • Brian Dattilo (Manager of Business Development, Waisman Biomanufacturing)
  • Mathilde Girard (Department Leader, Cell Therapy Innovation and Development, YposKesi)

The research also includes detailed profiles of the following players:

  • BioNTech Innovative Manufacturing Services
  • Brammer Bio
  • Cell and Gene Therapy Catapult
  • Cell Therapies
  • CELLforCURE
  • Cognate BioServices
  • Cryosite
  • FUJIFILM Cellular Dynamics
  • Japan Tissue Engineering
  • KBI Biopharma
  • Lonza
  • MaSTherCell
  • MEDINET
  • Nikon CeLL innovation
  • PCT, a Hitachi Group Company
  • Roslin Cell Therapies
  • Waisman Biomanufacturing
  • WuXi Advanced Therapies

For additional details, please visit https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing-market-2nd-edition-2018-2030/209.hl or email [email protected]

Contact:

Gaurav Chaudhary

+1-604-595-4954

Categories
News

Cell Therapy Manufacturing Market To Experience Significant Growth During The Forecast Period 2020-2029

The research study on Global Cell Therapy Manufacturing market 2019 presents an extensive analysis of current Cell Therapy Manufacturing market size, drivers, trends, opportunities, challenges, as well as key Cell Therapy Manufacturing market segments. Further, it explains various definitions and classification of the Cell Therapy Manufacturing industry, applications, and chain structure.In continuation of this data, the Cell Therapy Manufacturing report covers various marketing strategies followed by key players and distributors. Also explains Cell Therapy Manufacturing marketing channels, potential buyers and development history. The intent of global Cell Therapy Manufacturing research report is to depict the information to the user regarding Cell Therapy Manufacturing market forecast and dynamics for the upcoming years.The Cell Therapy Manufacturing study lists the essential elements which influence the growth of Cell Therapy Manufacturing industry. Long-term evaluation of the worldwide Cell Therapy Manufacturing market share from diverse countries and regions is roofed within the Cell Therapy Manufacturing report. Additionally, includes Cell Therapy Manufacturing type wise and application wise consumption figures.

“The Final Report will cover the impact analysis of COVID-19 on this industry.”

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10225722

After the basic information, the global Cell Therapy Manufacturing Market study sheds light on the Cell Therapy Manufacturing technological evolution, tie-ups, acquisition, innovative Cell Therapy Manufacturing business approach, new launches and Cell Therapy Manufacturing revenue. In addition, the Cell Therapy Manufacturing industry growth in distinct regions and Cell Therapy Manufacturing R&D status are enclosed within the report.The Cell Therapy Manufacturing study also incorporates new investment feasibility analysis of Cell Therapy Manufacturing. Together with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities, and challenges in the Cell Therapy Manufacturing market.

Global Cell Therapy Manufacturing Market Segmentation 2019:
The study also classifies the entire Cell Therapy Manufacturing market on basis of leading manufacturers, different types, various applications and diverse geographical regions.Overall Cell Therapy Manufacturing market is characterized by the existence of well-known global and regional Cell Therapy Manufacturing vendors. These established Cell Therapy Manufacturing players have huge essential resources and funds for Cell Therapy Manufacturing research as well as developmental activities. Also, the Cell Therapy Manufacturing manufacturers focusing on the development of new Cell Therapy Manufacturing technologies and feedstock. In fact, this will enhance the competitive scenario of the Cell Therapy Manufacturing industry.

The Leading Players involved in global Cell Therapy Manufacturing market are:
harmicell, Merck Group, Dickinson and Company, Thermo Fisher, Lonza Group, Miltenyi Biotec GmBH, Takara Bio Group, STEMCELL Technologies, Cellular Dynamics International, Becton, Osiris Therapeutics, Bio-Rad Laboratories, Inc., Anterogen, MEDIPOST, Holostem Terapie Avanazate, Pluristem Therapeutics, Brammer Bio, CELLforCURE, Gene Therapy Catapult EUFETS, MaSTherCell, PharmaCell, Cognate BioServices and WuXi AppTec.

Based on Therapy Type, the Cell Therapy Manufacturing market is categorized into:
• Allogeneic Cell Therapy
• Autologous Cell Therapy

Based on Technology, the Cell Therapy Manufacturing market is categorized into:
• Somatic Cell Technology
• Cell Immortalization Technology
• Viral Vector Technology
• Genome Editing Technology
• Cell Plasticity Technology
• 3D Technology

Based on Source, the Cell Therapy Manufacturing market is categorized into:
• IPSC’s
• Bone Marrow
• Umbilical Cord
• Adipose Tissue
• Neural Stem Cells

Based on Application, the Cell Therapy Manufacturing market is categorized into:
• Musculoskeletal
• Cardiovascular
• Gastrointestinal
• Neurological
• Oncology
• Dermatology
• Other

Global Cell Therapy Manufacturing Market Regional Analysis:
The companies in the world that deals with Cell Therapy Manufacturing mainly concentrate following regions.
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Global Cell Therapy Manufacturing Industry Report Covers following Topics:
01: Cell Therapy Manufacturing Market Overview
02: Global Cell Therapy Manufacturing Sales, Revenue (value) and Market Share by Players
03: Cell Therapy Manufacturing Market Sales, Revenue (Value) by Regions, Type and Application (2014-2018)
04: Region wise Top Players Cell Therapy Manufacturing Sales, Revenue and Price
05: worldwide Cell Therapy Manufacturing Industry Players Profiles/Analysis
06: Cell Therapy Manufacturing Cost Analysis
07: Industrial Chain, Cell Therapy Manufacturing Sourcing Strategy and Downstream Buyers
08: Cell Therapy Manufacturing Marketing Strategy Analysis, Distributors/Traders
09: Cell Therapy Manufacturing Industry Effect Factors Analysis
10: Global Cell Therapy Manufacturing Market Forecast (2019-2026)
11: Cell Therapy Manufacturing Research Findings and Conclusion
12: Appendix

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10225722

Worldwide Cell Therapy Manufacturing Market Different Analysis:
Competitors Review of Cell Therapy Manufacturing Market: Report presents the competitive landscape scenario seen among top Cell Therapy Manufacturing players, their company profile, revenue, sales, business tactics and forecast Cell Therapy Manufacturing industry situations.
Production Review of Cell Therapy Manufacturing Market: It illustrates the production volume, capacity with respect to major Cell Therapy Manufacturing regions, application, type, and the price.

Sales Margin and Revenue Accumulation Review of Cell Therapy Manufacturing Market: Eventually explains sales margin and revenue accumulation based on key regions, price, revenue, and Cell Therapy Manufacturing target consumer.

Supply and Demand Review of Cell Therapy Manufacturing Market: Coupled with sales margin, the report depicts the supply and demand seen in major regions, among key players and for every Cell Therapy Manufacturing product type. Also interprets the Cell Therapy Manufacturing import/export scenario.

Other key reviews of Cell Therapy Manufacturing Market: Apart from the above information, correspondingly covers the company website, number of employees, contact details of major Cell Therapy Manufacturing players, potential consumers and suppliers. Also, the strengths, opportunities, Cell Therapy Manufacturing market driving forces and market restraints are studied in this report.

Highlights of Global Cell Therapy Manufacturing Market Report:
* This report provides in detail analysis of the Cell Therapy Manufacturing and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2019 – 2029.
* It also elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for world Cell Therapy Manufacturing market.
* This study also provides key insights about Cell Therapy Manufacturing market drivers, restraints, opportunities, new product launches, approvals, regional outlook, and competitive strategies adopted by the leading Cell Therapy Manufacturing players.
* It profiles leading players in the worldwide Cell Therapy Manufacturing market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans.
* Insights from Cell Therapy Manufacturing report would allow marketers and management authorities of companies to make an informed decision with respect to their future product launches, market expansion, and Cell Therapy Manufacturing marketing tactics.
* The world Cell Therapy Manufacturing industry report caters to various stakeholders in Cell Therapy Manufacturing market. That includes investors, device manufacturers, distributors and suppliers for Cell Therapy Manufacturing equipment. Especially incorporates government organizations, Cell Therapy Manufacturing research and consulting firms, new entrants, and financial analysts.
*Various strategy matrices used in analyzing the Cell Therapy Manufacturing market would provide stakeholders vital inputs to make strategic decisions accordingly.
Global Cell Therapy Manufacturing Market Report Provides Comprehensive Analysis of Following:
– Cell Therapy Manufacturing Market segments and sub-segments
– Industry size & Cell Therapy Manufacturing shares
– Cell Therapy Manufacturing Market trends and dynamics
– Market Drivers and Cell Therapy Manufacturing Opportunities
– Supply and demand of world Cell Therapy Manufacturing industry
– Technological inventions in Cell Therapy Manufacturing trade
– Cell Therapy Manufacturing Marketing Channel Development Trend
– Global Cell Therapy Manufacturing Industry Positioning
– Pricing and Brand Strategy
– Distributors/Traders List enclosed in Positioning Cell Therapy Manufacturing Market.

Request For Full Report: https://www.kennethresearch.com/sample-request-10225722

Moreover, the report organizes to provide essential information on current and future Cell Therapy Manufacturing market movements, organizational needs and Cell Therapy Manufacturing industrial innovations. Additionally, the complete Cell Therapy Manufacturing report helps the new aspirants to inspect the forthcoming opportunities in the Cell Therapy Manufacturing industry. Investors will get a clear idea of the dominant Cell Therapy Manufacturing players and their future forecasts.

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research
Email: [email protected]
Phone: +1 313 462 0609

Categories
News

Cell Therapy Manufacturing Market to Reflect Impressive Growth Rate During 2020-2026

CMI presents an in-depth overview of the Global Cell Therapy Manufacturing Market Study, detailing the latest product/industry coverage and market forecasts and status by 2027. Market research is categorized as a key area to accelerate marketization. The current market is evolving its presence and some of the major players in the study are Pharmicell, Merck Group, Dickinson and Company, Thermo Fisher, Lonza Group, Miltenyi Biotec GmBH, Takara Bio Group, STEMCELL Technologies, Cellular Dynamics International, Becton, Osiris Therapeutics, Bio-Rad Laboratories, Inc., Anterogen, MEDIPOST, Holostem Terapie Avanazate, Pluristem Therapeutics, Brammer Bio, CELLforCURE, Gene Therapy Catapult EUFETS, MaSTherCell, PharmaCell, Cognate BioServices and WuXi AppTec.

This study focuses on the Global Cell Therapy Manufacturing market status, future forecast, growth opportunity, key market, and emerging players. The study objectives are to present the Cell Therapy Manufacturing growth in Key regions. In order to provide valuable insight by each key element of the market, the highest and slowest growing market segment in the study is described. Newmarket participants are emerging and are accelerating the transition in the antistatic market. Merger and acquisition activities are expected to change the market environment for this industry.

Get Free PDF Brochure Of this Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1728

Regional Markets: United States, Europe, China, Japan, Southeast Asia, India & Central & South America

List of Companies Mentioned: Pharmicell, Merck Group, Dickinson and Company, Thermo Fisher, Lonza Group, Miltenyi Biotec GmBH, Takara Bio Group, STEMCELL Technologies, Cellular Dynamics International, Becton, Osiris Therapeutics, Bio-Rad Laboratories, Inc., Anterogen, MEDIPOST, Holostem Terapie Avanazate, Pluristem Therapeutics, Brammer Bio, CELLforCURE, Gene Therapy Catapult EUFETS, MaSTherCell, PharmaCell, Cognate BioServices and WuXi AppTec.

1) Does Study provide Latest Impact on Market due to COVID & Slowdown?

Yes, the study has considered a chapter on Impact Analysis and this 2020 Edition of the report provides detailed analysis and its impact on growth trends and market sizing to better understand the current scenario.

2) How companies are selected or profiled in the report?

List of some players that are profiled in the report includes “Pharmicell, Merck Group, Dickinson and Company, Thermo Fisher, Lonza Group, Miltenyi Biotec GmBH, Takara Bio Group, STEMCELL Technologies, Cellular Dynamics International, Becton, Osiris Therapeutics, Bio-Rad Laboratories, Inc., Anterogen, MEDIPOST, Holostem Terapie Avanazate, Pluristem Therapeutics, Brammer Bio, CELLforCURE, Gene Therapy Catapult EUFETS, MaSTherCell, PharmaCell, Cognate BioServices and WuXi AppTec.”. the list is sorted to come up with a sample size of at least 50 to 100 companies having greater topline value to get their segment revenue for market estimation.

** List of companies mentioned may vary in the final report subject to Name Change / Merger etc.

3) Is it possible to narrow down business segments by Application of this study?

Yes, depending upon the data availability and feasibility check by our Research Analyst, a further breakdown in business segments by end-use application in relation to type can be provided (If applicable) by Revenue Size or Volume*.

4) What is the base year of the study? What time frame is covered in the report?

Furthermore, the years considered for the study are as follows:

Historical year – 2014-2019

Base year – 2019

Forecast period** – 2020 to 2027 [** unless otherwise stated]

Browse Complet Research Report Here: Cell Therapy Manufacturing Market 

** We will also include opportunities to utilize in micro markets that stakeholders can invest in, a detailed analysis of key competitors, and key services. **

Global Cell Therapy Manufacturing Market What to expect from this report:

– Focused Study on “Niche” Strategy and Market Development & penetration Scenario

– Top 10 Global Cell Therapy Manufacturing Companies in Global Market Share Analysis: Leaders and Laggards in 2017, 2019

– Gain strategic insights on competitor information to formulate effective R&D moves

– Identify emerging players and create effective counter-strategies to outpace competitive edge

– Identify important and diverse product types/services offering carried by major players for market development

And many more ……….

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: Global Cell Therapy Manufacturing MARKET LANDSCAPE

Market Entropy
Market segmentation analysis
Market characteristics

PART 06: Global Cell Therapy Manufacturing MARKET SIZING

Market definition
Market size and forecast
Market sizing

PART 07: Global Cell Therapy Manufacturing MARKET SEGMENTATION

Segmentation
Market opportunity
Comparison

PART 08: CUSTOMER LANDSCAPE

PART 10: DECISION FRAMEWORK

PART 09: REGIONAL LANDSCAPE

PART 11: MARKET DYNAMICS: DRIVERS, TRENDS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

 

Thanks for reading this article; you can also get individual chapter wise section or region wise report versions like North America, Europe, or Asia.

**Be Safe and Stay Home**

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: [email protected]
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Categories
News

Cell Therapy Manufacturing Market 2020 Report Including COVID-19 Impact Analysis and Forecast till 2029

The research study on Global Cell Therapy Manufacturing market 2019 presents an extensive analysis of current Cell Therapy Manufacturing market size, drivers, trends, opportunities, challenges, as well as key Cell Therapy Manufacturing market segments. Further, it explains various definitions and classification of the Cell Therapy Manufacturing industry, applications, and chain structure.In continuation of this data, the Cell Therapy Manufacturing report covers various marketing strategies followed by key players and distributors. Also explains Cell Therapy Manufacturing marketing channels, potential buyers and development history. The intent of global Cell Therapy Manufacturing research report is to depict the information to the user regarding Cell Therapy Manufacturing market forecast and dynamics for the upcoming years.The Cell Therapy Manufacturing study lists the essential elements which influence the growth of Cell Therapy Manufacturing industry. Long-term evaluation of the worldwide Cell Therapy Manufacturing market share from diverse countries and regions is roofed within the Cell Therapy Manufacturing report. Additionally, includes Cell Therapy Manufacturing type wise and application wise consumption figures.

“The Final Report will cover the impact analysis of COVID-19 on this industry.”

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10225722

After the basic information, the global Cell Therapy Manufacturing Market study sheds light on the Cell Therapy Manufacturing technological evolution, tie-ups, acquisition, innovative Cell Therapy Manufacturing business approach, new launches and Cell Therapy Manufacturing revenue. In addition, the Cell Therapy Manufacturing industry growth in distinct regions and Cell Therapy Manufacturing R&D status are enclosed within the report.The Cell Therapy Manufacturing study also incorporates new investment feasibility analysis of Cell Therapy Manufacturing. Together with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities, and challenges in the Cell Therapy Manufacturing market.

View Source of Related Reports : 

Cell Therapy Manufacturing Market  

 Cell Cryopreservation Market 

Botanical And Plant-Derived Drugs Market 

Alopecia Treatment Market 

Advanced Wound Care Market 

Global Cell Therapy Manufacturing Market Segmentation 2019:
The study also classifies the entire Cell Therapy Manufacturing market on basis of leading manufacturers, different types, various applications and diverse geographical regions.Overall Cell Therapy Manufacturing market is characterized by the existence of well-known global and regional Cell Therapy Manufacturing vendors. These established Cell Therapy Manufacturing players have huge essential resources and funds for Cell Therapy Manufacturing research as well as developmental activities. Also, the Cell Therapy Manufacturing manufacturers focusing on the development of new Cell Therapy Manufacturing technologies and feedstock. In fact, this will enhance the competitive scenario of the Cell Therapy Manufacturing industry.

The Leading Players involved in global Cell Therapy Manufacturing market are:
harmicell, Merck Group, Dickinson and Company, Thermo Fisher, Lonza Group, Miltenyi Biotec GmBH, Takara Bio Group, STEMCELL Technologies, Cellular Dynamics International, Becton, Osiris Therapeutics, Bio-Rad Laboratories, Inc., Anterogen, MEDIPOST, Holostem Terapie Avanazate, Pluristem Therapeutics, Brammer Bio, CELLforCURE, Gene Therapy Catapult EUFETS, MaSTherCell, PharmaCell, Cognate BioServices and WuXi AppTec.

Based on Therapy Type, the Cell Therapy Manufacturing market is categorized into:
• Allogeneic Cell Therapy
• Autologous Cell Therapy

Based on Technology, the Cell Therapy Manufacturing market is categorized into:
• Somatic Cell Technology
• Cell Immortalization Technology
• Viral Vector Technology
• Genome Editing Technology
• Cell Plasticity Technology
• 3D Technology

Based on Source, the Cell Therapy Manufacturing market is categorized into:
• IPSC’s
• Bone Marrow
• Umbilical Cord
• Adipose Tissue
• Neural Stem Cells

Based on Application, the Cell Therapy Manufacturing market is categorized into:
• Musculoskeletal
• Cardiovascular
• Gastrointestinal
• Neurological
• Oncology
• Dermatology
• Other

Global Cell Therapy Manufacturing Market Regional Analysis:
The companies in the world that deals with Cell Therapy Manufacturing mainly concentrate following regions.
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Global Cell Therapy Manufacturing Industry Report Covers following Topics:
01: Cell Therapy Manufacturing Market Overview
02: Global Cell Therapy Manufacturing Sales, Revenue (value) and Market Share by Players
03: Cell Therapy Manufacturing Market Sales, Revenue (Value) by Regions, Type and Application (2014-2018)
04: Region wise Top Players Cell Therapy Manufacturing Sales, Revenue and Price
05: worldwide Cell Therapy Manufacturing Industry Players Profiles/Analysis
06: Cell Therapy Manufacturing Cost Analysis
07: Industrial Chain, Cell Therapy Manufacturing Sourcing Strategy and Downstream Buyers
08: Cell Therapy Manufacturing Marketing Strategy Analysis, Distributors/Traders
09: Cell Therapy Manufacturing Industry Effect Factors Analysis
10: Global Cell Therapy Manufacturing Market Forecast (2019-2026)
11: Cell Therapy Manufacturing Research Findings and Conclusion
12: Appendix

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10225722

Worldwide Cell Therapy Manufacturing Market Different Analysis:
Competitors Review of Cell Therapy Manufacturing Market: Report presents the competitive landscape scenario seen among top Cell Therapy Manufacturing players, their company profile, revenue, sales, business tactics and forecast Cell Therapy Manufacturing industry situations.
Production Review of Cell Therapy Manufacturing Market: It illustrates the production volume, capacity with respect to major Cell Therapy Manufacturing regions, application, type, and the price.

Sales Margin and Revenue Accumulation Review of Cell Therapy Manufacturing Market: Eventually explains sales margin and revenue accumulation based on key regions, price, revenue, and Cell Therapy Manufacturing target consumer.

Supply and Demand Review of Cell Therapy Manufacturing Market: Coupled with sales margin, the report depicts the supply and demand seen in major regions, among key players and for every Cell Therapy Manufacturing product type. Also interprets the Cell Therapy Manufacturing import/export scenario.

Other key reviews of Cell Therapy Manufacturing Market: Apart from the above information, correspondingly covers the company website, number of employees, contact details of major Cell Therapy Manufacturing players, potential consumers and suppliers. Also, the strengths, opportunities, Cell Therapy Manufacturing market driving forces and market restraints are studied in this report.

Highlights of Global Cell Therapy Manufacturing Market Report:
* This report provides in detail analysis of the Cell Therapy Manufacturing and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2019 – 2029.
* It also elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for world Cell Therapy Manufacturing market.
* This study also provides key insights about Cell Therapy Manufacturing market drivers, restraints, opportunities, new product launches, approvals, regional outlook, and competitive strategies adopted by the leading Cell Therapy Manufacturing players.
* It profiles leading players in the worldwide Cell Therapy Manufacturing market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans.
* Insights from Cell Therapy Manufacturing report would allow marketers and management authorities of companies to make an informed decision with respect to their future product launches, market expansion, and Cell Therapy Manufacturing marketing tactics.
* The world Cell Therapy Manufacturing industry report caters to various stakeholders in Cell Therapy Manufacturing market. That includes investors, device manufacturers, distributors and suppliers for Cell Therapy Manufacturing equipment. Especially incorporates government organizations, Cell Therapy Manufacturing research and consulting firms, new entrants, and financial analysts.
*Various strategy matrices used in analyzing the Cell Therapy Manufacturing market would provide stakeholders vital inputs to make strategic decisions accordingly.
Global Cell Therapy Manufacturing Market Report Provides Comprehensive Analysis of Following:
– Cell Therapy Manufacturing Market segments and sub-segments
– Industry size & Cell Therapy Manufacturing shares
– Cell Therapy Manufacturing Market trends and dynamics
– Market Drivers and Cell Therapy Manufacturing Opportunities
– Supply and demand of world Cell Therapy Manufacturing industry
– Technological inventions in Cell Therapy Manufacturing trade
– Cell Therapy Manufacturing Marketing Channel Development Trend
– Global Cell Therapy Manufacturing Industry Positioning
– Pricing and Brand Strategy
– Distributors/Traders List enclosed in Positioning Cell Therapy Manufacturing Market.

Request For Full Report: https://www.kennethresearch.com/sample-request-10225722

Moreover, the report organizes to provide essential information on current and future Cell Therapy Manufacturing market movements, organizational needs and Cell Therapy Manufacturing industrial innovations. Additionally, the complete Cell Therapy Manufacturing report helps the new aspirants to inspect the forthcoming opportunities in the Cell Therapy Manufacturing industry. Investors will get a clear idea of the dominant Cell Therapy Manufacturing players and their future forecasts.

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research
Email: [email protected]
Phone: +1 313 462 0609